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Linoleic Acid in Adipose Tissue and Development of Ischemic
Stroke: A Danish Case-Cohort Study
Stine Krogh Venø, MD; Christian Sørensen Bork, MD; Marianne Uhre Jakobsen, MSc, PhD; Søren Lundbye-Christensen, MSc, PhD;
Flemming Winther Bach, MD, DMSc; Kim Overvad, MD, PhD; Erik Berg Schmidt, MD, DMSc
Background-—We investigated the association between the content of linoleic acid in adipose tissue, a biomarker of long-term
intake of linoleic acid, and the risk of ischemic stroke and its subtypes.
Methods and Results-—TheDanish cohort studyDiet, Cancer andHealth included 57 053patients aged50 to65 years at enrollment.
All participants had an adipose tissue biopsy performed at enrollment, while information on ischemic stroke during follow-up was
obtained from the Danish National Patient Register. Stroke diagnoses were all validated and classified according to the Trial of Org
10172 in Acute Stroke Treatment (TOAST) classification. Cases and a randomly drawn subcohort of 3500 patients had their fatty acid
composition in adipose tissue determined by gas chromatography. Hazard ratios with 95% confidence intervals were calculated using
weighted Cox proportional hazard regression. During 13.5 years of follow-up, 1879 ischemic stroke cases were identified, for which
1755adiposebiopsieswereavailable,whileadiposebiopsieswereavailable for3203participants in thesubcohort.Whencomparing the
highest and the lowest quartiles of adipose tissue content of linoleic acid therewasanegative associationwith the rateof total ischemic
stroke (hazard ratio, 0.78; 95% confidence interval, 0.65–0.93) and large artery atherosclerosis (hazard ratio, 0.61; 95% confidence
interval, 0.43–0.88), while there was an indication of a negative association with small-vessel occlusion (hazard ratio, 0.87; 95%
confidence interval, 0.69–1.11). There was no clear association with the rate of cardioembolism.
Conclusions-—The content of linoleic acid in adipose tissue was inversely associated with the risk of total ischemic stroke and
stroke caused by large artery atherosclerosis. ( J Am Heart Assoc. 2018;7:e009820. DOI: 10.1161/JAHA.118.009820.)
Key Words: adipose tissue • fatty acid • ischemic • stroke
L inoleic acid (LA) is an essential fatty acid, mainly derivedfrom vegetable oils, seeds, nuts, meats, and eggs,1 and
is the most widely consumed polyunsaturated fatty acid in the
human diet. Most previous long-term follow-up studies on
stroke have been based on self-reported dietary intake of LA
and were consequently affected by measurement error.
Interestingly, the content of LA in adipose tissue has been
shown to be an appropriate biomarker of long-term intake (6–
18 months) of LA2 and may reflect dietary intake of LA more
objectively.
Previous studies have reported an inverse association
between biomarkers of LA exposure and the risk of coronary
heart disease3,4 but these findings may not seem to apply to
ischemic stroke.5–8 Furthermore, only few studies with
biomarkers of LA exposure and the risk of ischemic stroke
have been undertaken and results have been inconsistent.
Moreover, LA has been suggested to play different roles in
different cerebral arteries9–11 and the influence of LA could
thus be different among subtypes of ischemic stroke. In this
study, we examined the association between the content of
LA in adipose tissue and incident ischemic stroke, as well as
subtypes classified according to The Trial of Org 10172 in
Acute Stroke Treatment (TOAST) classification,12 a system for
categorization mainly based on pathogenesis.
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Methods
Study Population
The study was based on the Diet, Cancer and Health cohort,
whichwas established to investigate diet and lifestyle factors as
risk factors for incident cancer and health and has been
described in detail elsewhere.13 Briefly, between 1993 and
1997, 160 725 men and women aged 50 to 64 years, living in
and around Copenhagen and Aarhus in Denmark, were invited
by mail to participate. The study recruited 57 053 participants.
All participants gave written informed consent, and the study
was approved by the relevant ethics committees and theDanish
Data Protection Agency. Because of the sensitive nature of the
data collected for this study, requests to access the data set
from qualified researchers trained in human subject confiden-
tiality protocols may be sent to the Diet, Cancer and Health
Steering Committee at the Danish Cancer Society (contact
information: Louise Hansen, louhan@cancer.dk). For the
current study, we used a case-cohort design, which included
a subcohort of 3500 participants randomly drawn from the
whole cohort and all incident cases. Participants with cancer or
stroke before recruitment or missing information on potential
confounders, risk factors, or the exposure under study were
excluded.
Covariates
At enrollment, the participants completed a lifestyle ques-
tionnaire regarding information on education status, smoking
habits, physical activity, history of hypercholesterolemia (self-
reported and/or use of lipid-lowering medication), hyperten-
sion (self-reported and/or use of antihypertensive medica-
tion), and diabetes mellitus (self-reported and/or use of
insulin). Anthropometric measurements (height, weight, and
waist circumference) were obtained by a laboratory techni-
cian. Body mass index was calculated as weight (kg)/height
(m)2. Information on alcohol intake and intake of foods was
obtained from a validated 192-item semiquantitative food
frequency questionnaire.14,15 Information on atrial fibrillation/
atrial flutter before baseline was obtained by linkage with the
National Patient Register. Discharge diagnoses from in-
hospital patients have been registered since 1977 using
International Classification of Diseases, Revision 8 (ICD-8),
discharge codes 42793 or 42794 and from 1993 ICD-10
discharge code I489.
Adipose Tissue Biopsies
Adipose tissue samples were taken at baseline from subcu-
taneous fat from the buttocks of all participants using a Luer
lock system (Terumo, Terumo Corp) consisting of a needle, a
venoject multisample Luer adaptor, and an evacuated blood
tube, according to the method of Beynen and Katan.16
Samples were flushed with nitrogen and stored at 150°C
until analysis. When analyzed, biopsies were thawed and
adipose tissue was removed to a glass and preheated at 50°C
for 10 minutes. According to International Union of Pure and
Applied Chemistry standard methods for analysis of oils, fats,
and derivatives, the fat was dissolved in heptane at 50°C and
fatty acids were transesterified by 2 mol/L potassium
hydroxide in methanol at 50°C for 2 minutes. The fatty acid
composition was determined by gas chromatography on a CP-
sil 88 60 m90.25 mm ID capillary column, consisting of a
highly substituted, stabilized cyanopropyl stationary phase,
using a Varian 3900 GC with a CP-8400 autosampler (Varian)
equipped with a flame ionization detector.17 Helium was used
as carrier gas, and individual fatty acids were identified using
commercially available standards (Nu-Chek Prep, Inc.). LA
content in adipose tissue was expressed as weight percent-
age of total fatty acids. The interassay coefficient of variation
for determination of LA in adipose tissue was 1.0%.
Identification of Ischemic Stroke Cases
The outcome in this study was defined as incident nonfatal
and fatal ischemic stroke as well as subtypes of ischemic
stroke. Potential stroke cases were identified by linkage to
the Danish National Patient Register where all hospital
contacts and discharge diagnoses from in-hospital patients
have been registered since 1977 and from 1995 diagnoses
from emergency departments and outpatient visits have been
recorded. Until December 31, 1993, possible stroke cases
included patients with an ICD-8 discharge code of 430, 431,
433, 434, 436.01, or 436.90 and from then on an ICD-10
discharge code of I60, I61, I63, or I64 as either a primary or
Clinical Perspective
What Is New?
• This is the largest study to investigate the association
between the content of linoleic acid in adipose tissue (a
long-term biomarker of intake) and ischemic stroke and its
subtypes.
• A high content of linoleic acid in adipose tissue was
associated with a lower risk of total ischemic stroke and
stroke caused by large artery atherosclerosis.
What Are the Clinical Implications?
• A high intake of linoleic acid may be associated with a lower
risk of ischemic stroke.
• Future guidelines for the prevention of ischemic stroke
should consider recommending linoleic acid as part of a
healthy diet.
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secondary diagnosis. Stroke was defined as a disease with
rapid onset of focal or global neurologic deficit of vascular
origin that persisted beyond 24 hours. Ischemic strokes were
divided into 5 subtypes according to the TOAST classifica-
tion:12 large artery atherosclerosis, cardioembolism, small-
vessel occlusion, stroke of other cause, and stroke of
undetermined cause. Stroke of other cause included cases
of stroke with rare causes. Stroke of undetermined cause
included cases where the pathogenesis could not be deter-
mined with any degree of confidence and included cases with
≥2 potential causes identified, as well as those with
incomplete evaluation. All case records were reviewed by a
physician with neurological experience. Diagnoses were
validated and characterized on the basis of clinical appear-
ance, computed tomography, magnetic resonance imaging
scan, autopsy records, spinal fluid examination, and other
relevant information.18 A random sample of 100 patients was
initially reviewed by a physician with neurological experience
and a senior consultant neurologist, and disagreements were
discussed at fixed intervals. Few disagreements were found
and agreed upon for the first 100 cases and after that only the
physician with neurological experience performed the TOAST
classification.
Statistical Analyses
Hazard ratios for total ischemic stroke and ischemic stroke
subtypes with 95% confidence intervals were calculated using
sex-stratified Cox proportional hazard regression models
allowing for different baseline hazards between sexes. Age
was the underlying time axis, and the analyses were
performed as if the full cohort had been included. The
Figure 1. Flowchart illustrating the subcohort and ischemic stroke cases from the Diet, Cancer and
Health Cohort. LA indicates linoleic acid.
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observation time for each participant was the period from the
date of enrollment until occurrence of ischemic stroke, death
from another cause, emigration, or end of follow-up (Decem-
ber 30, 2009). After proper exclusion, each patient was
assigned weights, 1 for cases and N/n for noncases in the
subcohort, with N being the number of noncases in the cohort
and n being the number of noncases in the subcohort.19 Stata
uses as a default robust variance estimation when applying
weighted Cox regression, and hence the variance was
properly adjusted. For each stroke subtype, only patients
with a diagnosis of the subtype in question were included as
cases. The cases of other subtypes that appeared in the
subcohort were censored at the time of diagnosis as their risk
of a subsequent stroke will change. The analyses were
planned a priori and included predefined potential con-
founders and risk factors. We used 3 different models: model
1A representing an age- and sex-adjusted model that included
age at baseline (years, continuous) and sex allowing for
separate baseline hazards. The second model (model 1B)
representing an educational- and lifestyle-adjusted model
included the same covariates as model 1A plus the following
potential confounders and risk factors: educational status (<7,
8–10, and >10 years), waist circumference adjusted for body
mass index (continuous), smoking status (noncurrent, current
<15, ≥15 g of tobacco per day), physical activity (h/wk,
continuous), alcohol intake (continuous), and alcohol abstain
(yes, no). In model 2, possible intermediate variables were
added to model 1A including hypertension (yes, no, unknown),
hypercholesterolemia (yes, no, unknown), diabetes mellitus
(yes, no, unknown), and atrial fibrillation/atrial flutter (yes, no)
before baseline. Continuous variables were included using
restricted cubic splines with 3 knots. Analyses were per-
formed with LA content in adipose tissue divided into quartiles
using the lowest quartile as the reference. Furthermore, LA
content in adipose tissue was included as a continuous
variable and spline functions were plotted to visually assess
the shape of the association with the 12.5 percentile (median
in the lowest quartile) of adipose tissue content of LA as a
reference. The spline functions were graphed for the 2.5 to
97.5 percentiles of the exposure distribution. The proportional
hazards assumption in the Cox regression analyses
was evaluated by a log-rank test based on Schoenfeld
residuals. All analyses were conducted using Stata 14
(StataCorp). Two-sided P values <0.05 were considered
statistically significant.
Results
A total of 57 053 men and women agreed to participate
(Figure 1). Of those, 569 participants had cancer and 582
participants had a stroke before baseline and were subse-
quently excluded. A further 564 participants were excluded as
a result of missing information on potential confounders and
risk factors. The subcohort included 3410 participants for
whom adipose tissue biopsies were available for 3203. During
a median follow-up of 13.5 years, a total of 1879 ischemic
stroke cases were identified. Adipose tissue biopsies were
Table 1. Baseline Characteristics of Participants in the
Subcohort and Ischemic Stroke Cases
Characteristics Subcohort (n=3203)
Ischemic Stroke
Cases (n=1755)
Age at enrollment, y 56.3 (50.7–64.2) 58.9 (51.0–64.6)
Sex, % (No.)
Male 54.0 (1731) 61.9 (1087)
Female 46.0 (1472) 38.1 (668)
Education, % (No.)
<7 y 32.9 (1053) 41.0 (719)
8 to 10 y 45.0 (1440) 42.6 (747)
>10 y 22.2 (710) 16.5 (289)
Body mass index, kg/m2 25.7 (20.6–33.4) 26.3 (21.0–34.9)
Waist circumference, cm 90.0 (69.5–111.0) 93.0 (72.0–116.0)
Smoking status, % (No.)
Noncurrent smoker 63.9 (2047) 50.5 (887)
Current <15 g/d 13.6 (436) 15.4 (271)
Current ≥15 g/d 22.5 (720) 34.0 (597)
Physical activity, h/wk 2.5 (0.0–10.5) 2.0 (0.0–11.0)
Alcohol intake, g/d 13.7 (0.8–65.4) 15.0 (0.5–79.4)
Abstains from alcohol, % (No.)
Yes 2.1 (68) 3.0 (52)
No 97.9 (3135) 97.0 (1703)
Hypercholesterolemia, % (No.)
Yes 7.9 (253) 10.8 (190)
No 49.4 (1581) 48.4 (850)
Unknown 42.7 (1369) 40.8 (715)
Hypertension, % (No.)
Yes 15.7 (502) 28.8 (505)
No 71.7 (2297) 57.7 (1012)
Unknown 12.6 (404) 13.6 (238)
Diabetes mellitus, % (No.)
Yes 2.0 (65) 4.3 (76)
No 92.9 (2974) 89.6 (1572)
Unknown 5.1 (164) 6.1 (107)
Atrial fibrillation/atrial flutter, % (No.)
Yes 0.9 (30) 1.4 (24)
No 99.1 (3173) 98.6 (1731)
Values are expressed as medians (5th–95th percentile) unless otherwise indicated.
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Table 2. Adipose Tissue Content of LA in Quartiles and Association With Ischemic Stroke and Ischemic Stroke Subtypes
Type of Ischemic Stroke and Quartile Content of LA No.
Model 1A* Model 1B† Model 2‡
HR (95% CI) HR (95% CI) HR (95% CI)
Total ischemic stroke 1755
Q1§ 555 1 1 1
Q2k 439 0.84 (0.71–0.99) 0.92 (0.77–1.09) 0.84 (0.71–0.99)
Q3¶ 399 0.76 (0.65–0.90) 0.85 (0.71–1.02) 0.77 (0.65–0.92)
Q4# 362 0.66 (0.56–0.79) 0.78 (0.65–0.93) 0.65 (0.54–0.77)
Ptrend P<0.001 P=0.004 P<0.001
Large artery atherosclerosis 300
Q1§ 100 1 1 1
Q2k 67 0.71 (0.51–0.98) 0.72 (0.51–1.01) 0.71 (0.51–0.99)
Q3¶ 77 0.82 (0.60–1.12) 0.84 (0.61–1.17) 0.84 (0.61–1.17)
Q4# 56 0.57 (0.40–0.80) 0.61 (0.43–0.88) 0.58 (0.41–0.83)
Ptrend P=0.004 P=0.021 P=0.010
Cardioembolism 99
Q1§ 31 1 1 1
Q2k 31 1.08 (0.65–1.81) 1.28 (0.75–2.19) 1.03 (0.61–1.74)
Q3¶ 17 0.59 (0.32–1.09) 0.71 (0.37–1.37) 0.57 (0.30–1.06)
Q4# 20 0.67 (0.38–1.18) 0.86 (0.46–1.59) 0.57 (0.31–1.07)
Ptrend P=0.052 P=0.311 P=0.024
Small-vessel occlusion 781
Q1§ 250 1 1 1
Q2k 184 0.77 (0.62–0.96) 0.90 (0.72–1.13) 0.78 (0.62–0.97)
Q3¶ 174 0.73 (0.59–0.91) 0.87 (0.69–1.03) 0.74 (0.59–0.92)
Q4# 173 0.70 (0.56–0.88) 0.87 (0.69–1.11) 0.69 (0.55–0.87)
Ptrend P=0.002 P=0.236 P=0.001
Stroke of other causes 91
Q1§ 31 1 1 1
Q2k 25 0.82 (0.48–1.42) 0.89 (0.51–1.55) 0.85 (0.50–1.45)
Q3¶ 13 0.44 (0.23–0.85) 0.45 (0.22–0.92) 0.45 (0.23–0.87)
Q4# 22 0.72 (0.41–1.26) 0.76 (0.42–1.39) 0.73 (0.42–1.31)
Ptrend P=0.107 P=0.173 P=0.127
Stroke of undetermined cause 484
Q1§ 143 1 1 1
Q2k 132 0.98 (0.76–1.28) 1.04 (0.79–1.37) 0.98 (0.75–1.28)
Q3¶ 118 0.89 (0.68–1.17) 0.93 (0.70–1.23) 0.90 (0.68–1.18)
Q4# 91 0.66 (0.50–0.88) 0.74 (0.54–1.00) 0.63 (0.46–0.84)
Ptrend P=0.003 P=0.036 P=0.002
CI indicates confidence interval; HR, hazard ratio; LA, linoleic acid.
*Model 1A included age at inclusion. Sex was included by allowing for different baseline hazards.
†Model 1B includes model 1A plus alcohol intake, alcohol abstain, waistline adjusted for body mass index, education status, smoking, and physical activity.
‡Model 2 includes model 1A plus hypertension, hypercholesterolemia, diabetes mellitus, and atrial fibrillation/atrial flutter.
§Q1<9.55.
kQ2=9.55–10.59.
¶Q3=10.6–11.68.
#Q4>11.68.
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available for 1755 ischemic stroke cases (113 appeared in the
subcohort). Cases included 300 strokes caused by large
artery atherosclerosis, 781 strokes caused by small-vessel
occlusion, 99 strokes caused by cardioembolism, 91 strokes
of other causes, and 484 strokes of undetermined causes.
Baseline characteristics of ischemic stroke cases and the
subcohort are given in Table 1. Case participants were older
and more likely men compared with the subcohort partici-
pants. Furthermore, compared with the subcohort, case
participants had less education, higher body mass index,
larger waist circumference, and were more likely to be
smokers and have higher alcohol intake and were less
physically active. Finally, case participants more often had
hypercholesterolemia, hypertension, diabetes mellitus, and
atrial fibrillation/atrial flutter compared with the subcohort
participants. Table S1 shows baseline characteristics accord-
ing to quartiles of LA content in adipose tissue for participants
in the subcohort and for case participants with ischemic
stroke.
A higher adipose tissue content of LA was associated with a
lower rate of total ischemic stroke (hazard ratio, 0.78; 95%
confidence interval, 0.65–0.93) when comparing the highest
with the lowest quartile of adipose tissue content of LA
(Table 2 and Figure 2). A test for a linear trend across quartiles
was statistically significant (P=0.004). We also observed a
dose-dependent negative association between adipose tissue
content of LA and the rate of large artery atherosclerosis
(hazard ratio, 0.61; 95% confidence interval, 0.43–0.88)
(Table 2 and Figure 2). When testing for a linear trend across
quartiles, a statistically significant negative association was
found (P=0.021). For cardioembolism, no consistent associa-
tions were found with the content of LA in adipose tissue
(Table 2 and Figure 2). There was an indication of a negative
association between the content in adipose tissue of LA and
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Figure 2. Spline curves for adipose tissue content of linoleic acid (LA) in percentage of total fatty acids and the risk of incident total ischemic
stroke, large artery atherosclerosis, cardioembolism, and small-vessel occlusion. Data presented for model 1B, adjusting for educational and
lifestyle factors. The 2.5 to 97.5 percentile of LA is shown, with the 12.5 percentile (median in the lowest quartile) as reference. Black lines show
the hazard ratios and the shaded grey areas show the 95% confidence intervals. The 25, 50, and 75 percentiles of LA are shown by vertical lines.
DOI: 10.1161/JAHA.118.009820 Journal of the American Heart Association 6
Linoleic Acid and Ischemic Stroke Venø et al
O
R
IG
IN
A
L
R
E
S
E
A
R
C
H
D
ow
nloaded from
 http://ahajournals.org by on O
ctober 17, 2018
the risk of small-vessel occlusion (hazard ratio, 0.87; 95%
confidence interval, 0.69–1.11 for the highest quartile com-
pared with the lowest quartile) (Table 2 and Figure 2).
Figure 3 illustrates the underlying dietary patterns of
different food and beverage groups for participants according
to the content of LA in adipose tissue in the subcohort. Results
indicate that compared with participants in the lowest quartile
of adipose tissue LA content, participants with a high content
of adipose tissue LA tended to consume less alcohol, fatty
dairy products, butter and other animal fat, eggs, red meat,
snacks and fatty potatoes, and soft drinks and juices, and less
fruits, vegetables, whole grain cereals, vegetable oils and
mayonnaises, margarines, lean dairy products, and poultry.
Discussion
We found a statistically significant lower rate of total ischemic
stroke and large artery atherosclerosis associated with the
content of LA in adipose tissue, whereas there was an
indication of a negative association for small-vessel occlusion.
For cardioembolism, no clear association was found.
We used adipose tissue biopsies to investigate LA in relation
to the risk of ischemic stroke and subtypes. Because of a slow
turnover time, the fatty acid content in adipose tissuemay serve
as an objective, long-term measure of dietary intake of fatty
acids in the previous 6 to 18 months, and is considered the gold
standard for long-term dietary intake of fatty acids.2,20 Also, the
content of LA in adipose tissue is known to be strongly
correlated with dietary LA intake.21,22 Another strength of the
study is that ischemic stroke diagnoses were validated and
subclassified according to the TOAST classifications.12 Only
few participants were lost to follow-up, which limits the risk of
selection bias. Furthermore, information bias is unlikely to have
affected the results, as information on ischemic stroke cases
was obtained by linkage with the Danish National Patient
Register and thus case ascertainment was independent of LA
measurement. Detailed information on potential confounders
and risk factors in the study limits but does not eliminate the
risk of residual confounding. Only baseline information on
adipose tissue content of LA and potential confounders were
included, which is a limitation, because changes in dietary
habits and lifestyle risk factors may have occurred over time.
Information on atrial fibrillation/atrial flutter was ascertained
by linkage with the Danish National Patient Register, but
participants with asymptomatic atrial fibrillation/atrial flutter
might not have been admitted for hospital evaluation and,
therefore, atrial fibrillation/atrial flutter might have been
undercaptured. In addition, the study cohort included only
Danish, middle-aged, white participants and the study results
may not be generalizable to other ethnicities or age groups.
When we adjusted for educational and lifestyle factors (model
1B), the pattern of association remained the same as in the age-
and sex-adjusted model (model 1A), although the associations
were weakened, which could indicate confounding. Hyperten-
sion, hypercholesterolemia, diabetes mellitus, and atrial fibril-
lation/atrial flutter are known risk factors for ischemic stroke
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Figure 3. Radar chart illustrating the percentage-wise difference in energy-adjusted median intake of 21
groups of foods and beverages for participants in the subcohort with the lowest and the highest adipose tissue
content of linoleic acid. First quartile is illustrated with a black line and fourth quartile with a gray line.
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but they are also possible intermediate factors in the causal
pathway between LA and ischemic stroke; hence, adjustment
may introduce selection stratification bias. We considered
model 1B our main analysis since the results have a clear and
unbiased interpretation. The radar chart (Figure 3) shows that a
high content of LA in adipose tissue was associated with overall
healthier eating habits. The study results can therefore not
directly be interpreted as associations for LA independently of
the diet contributing to LA intake. Since there is no clear
indication of a different risk of developing ischemic stroke
between the 2 sexes, the analyses were not performed
separately. Instead, we analyzed data assuming equal associ-
ation of the exposure for both sexes but allowing for different
baseline hazards. We used a case-cohort design, which is a
good way to analyze various exposures and outcomes. Analysis
of adipose tissue biopsy for fatty acid composition is expensive
and time consuming and would for these reasons have been
impossible to perform in the full cohort of >57 000 patients. By
using weighed Cox proportional hazard regression, the statis-
tical analyses were performed as if the full cohort had been
included.
Only a few studies relating biomarkers of LA to ischemic
stroke have been published. However, in a follow-up study
with 168 ischemic stroke cases, an inverse association was
found between serum LA and the risk of ischemic stroke.5 In
contrast, no association between serum LA and risk of
ischemic stroke was found in a case-control study with 93
ischemic stroke cases.6 In another case-control study7 with
122 cases of ischemic stroke, statistically significant
negative associations were found between serum LA and
total ischemic stroke and small-vessel occlusion, whereas
negative but not statistically significant associations for large
artery atherosclerosis and cardioembolism were observed.
Furthermore, a case-control study8 with 34 ischemic stroke
cases found that serum LA content was significantly lower in
patients with small-vessel occlusions and large artery
atherosclerosis than among controls. Our findings of an
inverse association for large artery atherosclerosis and
indication of an inverse association for small-vessel occlu-
sion with a higher content of LA in adipose tissue are in
agreement with these findings. The effect of LA on ischemic
stroke may act through several mechanisms. Numerous
studies have thus reported a beneficial effect of LA on blood
lipids and blood pressure.23,24 Since hypercholesterolemia
and hypertension have a different impact on the large
precerebral arteries and the small cerebral arteries,9,25,26
this could partly explain the observed differences in risk
between subtypes of ischemic stroke. We found a lower risk
of large artery atherosclerosis and indications of a negative
association between LA content in adipose tissue and
small-vessel occlusion. Although there are more cases with
small-vessel occlusion, the negative association between LA
and total ischemic stroke might be driven by cases of large
artery atherosclerosis.
Stroke of other causes and stroke of undetermined causes
belong to the TOAST classification and results were accordingly
reported.Thesubtypestrokeofothercauses includescaseswith
rare causes of strokeof different origin,while the subtype stroke
of undetermined causes includes cases of stroke with ≥2
potential causes identified, as well as those with incomplete
evaluation.12 We conducted analyses on these outcomes but
decided not to discuss them further because the results were
without clear interpretation.
Conclusions
The content of LA in adipose tissue was inversely associated
with the risk of total ischemic stroke, and stroke caused by
large artery atherosclerosis, while there was an indication of a
negative association between adipose tissue LA and small-
vessel occlusion. There was no clear association between the
content of LA in adipose tissue and cardioembolism.
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Table S1. Baseline characteristics according to quartiles of LA in adipose tissue for participants in the 
subcohort and ischemic stroke cases. 
Characteristics Subcohort (n = 3,203)  Ischemic stroke cases (n = 1,755) 
Age at enrolment (year) 
Q1§ 56.8 (50.8-64.3) 58.7 (51.1-64.6) 
Q2| | 55.9 (50.7-64.0) 58.3 (50.9-64.4) 
Q3# 55.8 (50.7-64.1) 59.0 (51.0-64.7) 
Q4* * 56.7 (50.6-64.1) 59.4 (51.4-64.7) 
Sex (%) 
Male  
Q1§ 15.2 (487) 21.1 (370) 
Q2| | 13.7 (440) 16.1 (282) 
Q3# 12.7 (407) 13.0 (228) 
Q4* * 12.4 (397) 11.8 (207) 
Female 
Q1§ 9.8 (317) 10.5 (185) 
Q2| | 11.3 (363) 8.9 (157) 
Q3# 12.1 (386) 9.7 (171) 
Q4* * 12.7 (406) 8.8 (155) 
Education (%) 
<7 years 
Q1§ 8.3 (265) 13.2 (232) 
Q2| | 8.0 (256) 10.7 (188) 
Q3# 8.6 (276) 8.9 (157) 
Q4* * 8.0 (256) 8.1 (142) 
8-10 years
Q1§ 10.9 (348) 13.1 (230) 
Q2| | 11.9 (381) 10.3 (181) 
Q3# 10.7 (344) 9.9 (174) 
Q4* * 11.5 (367) 9.2 (162) 
>10 years
Q1§ 6.0 (191) 5.3 (93) 
Q2| | 5.2 (166) 4.0 (70) 
Q3# 5.4 (173) 3.9 (68) 
Q4* * 5.6 (180) 3.3 (58) 
BMI (kg/m2) 
Q1§ 26.2 (20.5-33.6) 26.4 (21.0-35.6) 
Q2| | 26.0 (20.5-33.6) 26.7 (21.3-35.0) 
Q3# 25.9 (21.2-33.4) 26.2 (20.9-35.3) 
Q4* * 25.1 (20.6-32.8) 25.8 (20.5-33.3) 
Waist circumference (cm) 
Q1§ 93.0 (70.0-113.0) 94.0 (73.0-119.0) 
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Q2| |  90.0 (69.0-111.0) 95.0 (73.0-116.0) 
Q3#  90.0 (96.5-111.0) 92.0 (71.0-114.0) 
Q4* *  88.0 (69.0-107.0) 91.0 (110.0-33.3) 
Smoking status (%)      
 Non current smoker      
Q1§   13.4 (429) 12.1 (213) 
Q2| |   15.8 (507) 12.6 (221) 
Q3#   16.7 (536) 12.4 (217) 
Q4* *   18.0 (575) 13.4 (236) 
 Current<15 g/d      
Q1§   3.6 (116) 5.1 (89) 
Q2| |   3.5 (111) 3.6 (63) 
Q3#   3.4 (110) 3.7 (65) 
Q4* *   3.1 (99) 3.1 (54) 
 Current >=15 g/d      
Q1§   8.0 (259) 14.4 (253) 
Q2| |   5.8 (185) 8.8 (155) 
Q3#   4.6 (147) 6.7 (117) 
Q4* *   4.0 (129) 4.1 (72) 
Physical activity 
(hours/week) 
     
Q1§  2.0 (0.0-10.0) 1.5 (0.0-11.0) 
Q2| |  2.0 (0.0-10.0) 2.0 (0.0-12.0) 
Q3#  2.5 (0.0-11.0) 2.0 (0.0-11.0) 
Q4* *  2.5 (0.0-11.5) 2.0 (0.0-10.0) 
Alcohol intake (g/d)      
Q1§  23.9 (1.0-88.6) 30.4 (0.2-99.5) 
Q2| |  14.3 (1.4-64.9) 15.6 (0.9-66.2) 
Q3#  12.1 (0.7-46.0) 11.7 (0.6-49.0) 
Q4* *  11.2 (0.6-41.9) 8.8 (71.0-110.0) 
Alcohol abstainer (%)      
 Yes      
Q1§   0.7 (21) 1.2 (21) 
Q2| |   0.3 (11) 0.6 (10) 
Q3#   0.6 (18) 0.5 (8) 
Q4* *   0.6 (18) 0.7 (13) 
 No      
Q1§   24.4 (783) 30.4 (534) 
Q2| |   24.7 (792) 24.4 (429) 
Q3#   24.2 (775) 22.2 (391) 
Q4* *   24.5 (785) 19.9 (349) 
Hypercholesterolemia (%)      
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 Yes      
Q1§   1.2 (40) 2.6 (45) 
Q2| |   1.3 (41) 2.2 (38) 
Q3#   2.2 (72) 2.6 (46) 
Q4* *   3.1 (100) 3.5 (61) 
 No      
Q1§   12.2 (391) 14.5 (255) 
Q2| |   12.5 (399) 17.8 (224) 
Q3#   12.0 (384) 11.7 (206) 
Q4* *   12.7 (407) 9.4 (165) 
 Unknown      
Q1§   11.6 (373) 14.5 (255) 
Q2| |   11.3 (363) 10.1 (177) 
Q3#   10.5 (337) 8.4 (147) 
Q4* *   9.2 (296) 7.8 (136) 
Hypertension (%)      
 Yes      
Q1§   4.1 (131) 9.1 (159) 
Q2| |   3.8 (121) 6.6 (116) 
Q3#   3.6 (114) 7.0 (123) 
Q4* *   4.2 (136) 6.1 (107) 
 No      
Q1§   17.7 (568) 17.2 (302) 
Q2| |   17.5 (561) 15.1 (265) 
Q3#   18.4 (589) 13.3 (234) 
Q4* *   18.1 (579) 12.0 (211) 
 Unknown      
Q1§   4.7 (105) 5.4 (94) 
Q2| |   3.8 (121) 3.3 (58) 
Q3#   2.8 (90) 2.4 (42) 
Q4* *   2.7 (88) 2.5 (44) 
Diabetes mellitus (%)      
 Yes      
Q1§   0.8 (25) 1.4 (25) 
Q2| |   0.3 (10) 1.2 (21) 
Q3#   0.6 (18) 0.7 (12) 
Q4* *   0.4 (12) 1.0 (18) 
 No      
Q1§   22.8 (730) 27.2 (478) 
Q2| |   23.4 (750) 22.9 (402) 
Q3#   23.0 (736) 21.0 (369) 
Q4* *   23.7 (758) 18.4 (323) 
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Median (5th-95th percentile) or % (n).  
§Q1 < 9.55  
| |Q2 = 9.55 - 10.59 
#Q3 = 10.6 – 11.68 
* *Q4 > 11.68   
 Unknown      
Q1§   1.5 (49) 3.0 (52) 
Q2| |   1.3 (43) 0.9 (16) 
Q3#   1.2 (39) 1.0 (18) 
Q4* *   1.0 (33) 1.2 (21) 
Atrial fibrillation (%)      
 Yes      
Q1§   0.2 (6) 0.3 (6) 
Q2| |   0.2 (8) 0.2 (3) 
Q3#   0.2 (6) 0.3 (6) 
Q4* *   0.3 (10) 0.5 (9) 
 No      
Q1§   24.9 (798) 31.3 (549) 
Q2| |   24.8 (795) 24.8 (436) 
Q3#   24.6 (787) 22.4 (393) 
Q4* *   24.8 (793) 20.1 (353) 
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